Denver, CO, May 05, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral ...
NORTH CHICAGO, Ill., May 29, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Commission (EC) has authorized an expanded label for VENCLYXTO ® (venetoclax) to include use in ...
PanTher Therapeutics ("PanTher" or the "Company"), a clinical-stage company redefining early cancer treatment with therapeutic implants administered directly at the tumor site, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results